BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19226197)

  • 1. Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence.
    Naing S; Collins BJ; Schneider AB
    Thyroid; 2009 May; 19(5):479-85. PubMed ID: 19226197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer.
    Rumyantsev PO; Saenko VA; Ilyin AA; Stepanenko VF; Rumyantseva UV; Abrosimov AY; Lushnikov EF; Rogounovitch TI; Shibata Y; Mitsutake N; Tsyb AF; Yamashita S
    J Clin Endocrinol Metab; 2011 Feb; 96(2):385-93. PubMed ID: 21084394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence.
    Abraham E; Tran B; Roshan D; Graham S; Lehane C; Wykes J; Campbell P; Ebrahimi A
    ANZ J Surg; 2018 Nov; 88(11):1193-1197. PubMed ID: 29701284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
    Dehbi HM; Mallick U; Wadsley J; Newbold K; Harmer C; Hackshaw A
    Lancet Diabetes Endocrinol; 2019 Jan; 7(1):44-51. PubMed ID: 30501974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
    Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 12. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.
    Banerjee M; Wiebel JL; Guo C; Gay B; Haymart MR
    BMJ; 2016 Jul; 354():i3839. PubMed ID: 27443325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Risk Stratification in Stage I Papillary Thyroid Cancer Patients Younger Than 45 Years of Age.
    Sung TY; Cho JW; Lee YM; Lee YH; Kwon H; Jeon MJ; Kim WG; Choi YJ; Song DE; Chung KW; Yoon JH; Hong SJ
    Thyroid; 2017 Nov; 27(11):1400-1407. PubMed ID: 28847226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and clinical outcomes in Chernobyl-related paediatric thyroid cancers: what do we know now? What can we expect in the future?
    Tuttle RM; Vaisman F; Tronko MD
    Clin Oncol (R Coll Radiol); 2011 May; 23(4):268-75. PubMed ID: 21324656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer.
    Beasley NJ; Lee J; Eski S; Walfish P; Witterick I; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2002 Jul; 128(7):825-8. PubMed ID: 12117344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
    Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
    Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.
    Wang LY; Ghossein R; Palmer FL; Nixon IJ; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
    Thyroid; 2015 Sep; 25(9):993-8. PubMed ID: 26122000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
    Llamas-Olier AE; Cuéllar DI; Buitrago G
    Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.